pargyline has been researched along with Hyperoxia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, YU | 1 |
| Watanabe, K | 1 |
| Higuchi, H | 1 |
| Satoh, T | 1 |
| Vizi, ES | 1 |
1 other study available for pargyline and Hyperoxia
| Article | Year |
|---|---|
Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Inhalation; Animals; Clorgyline; Corpus Striatum; Do | 2001 |